About
Scope & Aims
Editorial office
Editorial board
Reviewers
Ethical standards and procedures
Abstracting and indexing
Contact
Articles & Issues
Current issue
Articles in press
Archive
For Authors
General rules
Guide for authors
Templates
Publication charge
For Reviewers
Guide for reviewers
Our reviewers
ORIGINAL PAPER
Response of glycaemic control to extravascular low level laser therapy in type 2 diabetic patients: a randomized clinical trial
1
Department of Cardiovascular/Respiratory Disorders and Geriatrics, Faculty of Physical Therapy, Cairo University, Giza, Egypt
2
Faculty of Medicine Kasr Al-Aini, Cairo University, Giza, Egypt
3
Department of Medical Rehabilitation, College of Applied Medical Sciences, King Khalid University, Abha, Saudi Arabia
Submission date: 2020-05-27
Acceptance date: 2020-07-07
Publication date: 2021-11-30
Physiother Quart. 2021;29(4):42-48
KEYWORDS
TOPICS
ABSTRACT
Introduction:
The aim of this study was to investigate the effectiveness of low level laser therapy (extravascular laser blood irradiation) on glycaemic levels in type 2 diabetes mellitus patients.
Methods:
Sixty patients with type 2 diabetes mellitus lasting more than 1 year, aged 45–60 years, receiving 2 types of medication (metformin and sulphonylurea) were randomly divided into 2 equal groups. The laser group received laser therapy (low level laser therapy, 3 sessions/week for 12 weeks) combined with their prescribed hypoglycaemic medications, while the comparative group received the prescribed hypoglycaemic medications only. Glycated haemoglobin (HbA1c), fasting plasma glucose, 75-g oral glucose tolerance, and fasting C-peptide were evaluated before and after the therapy in both groups, while the glycaemic level was checked before and after each laser session to determine the acute effect of laser.
Results:
All variables were tested with mixed MANOVA, with a statistical significance level at p < 0.05. There was a significant post-treatment decrease in HbA1c, fasting plasma glucose, and oral glucose tolerance in the laser group compared with the control group (p < 0.05), but no significant difference for post-treatment fasting C-peptide between the groups (p > 0.05). Regarding the acute effect of laser, a significant decrease was observed in the blood glucose level after the laser sessions (p = 0.0001), with a mean difference of 22.73 mg/dl.
Conclusions:
The study showed a considerable positive effect of extravascular low level laser therapy on the glycaemic levels in type 2 diabetes mellitus patients.
The aim of this study was to investigate the effectiveness of low level laser therapy (extravascular laser blood irradiation) on glycaemic levels in type 2 diabetes mellitus patients.
Methods:
Sixty patients with type 2 diabetes mellitus lasting more than 1 year, aged 45–60 years, receiving 2 types of medication (metformin and sulphonylurea) were randomly divided into 2 equal groups. The laser group received laser therapy (low level laser therapy, 3 sessions/week for 12 weeks) combined with their prescribed hypoglycaemic medications, while the comparative group received the prescribed hypoglycaemic medications only. Glycated haemoglobin (HbA1c), fasting plasma glucose, 75-g oral glucose tolerance, and fasting C-peptide were evaluated before and after the therapy in both groups, while the glycaemic level was checked before and after each laser session to determine the acute effect of laser.
Results:
All variables were tested with mixed MANOVA, with a statistical significance level at p < 0.05. There was a significant post-treatment decrease in HbA1c, fasting plasma glucose, and oral glucose tolerance in the laser group compared with the control group (p < 0.05), but no significant difference for post-treatment fasting C-peptide between the groups (p > 0.05). Regarding the acute effect of laser, a significant decrease was observed in the blood glucose level after the laser sessions (p = 0.0001), with a mean difference of 22.73 mg/dl.
Conclusions:
The study showed a considerable positive effect of extravascular low level laser therapy on the glycaemic levels in type 2 diabetes mellitus patients.
REFERENCES (25)
1.
American Diabetes Association. Introduction: Standards of medical care in diabetes – 2018. Diabetes Care. 2018;41(Suppl. 1):S1–S2; doi: 10.2337/dc18-Sint01.
2.
Baynest HW. Classification, pathophysiology, diagnosis and management of diabetes mellitus. J Diabetes Metab. 2015;6(5):1000541; doi: 10.4172/2155-6156.1000541.
3.
Ido Y, Vindigni A, Chang K, Stramm L, Chance R, Heath WF, et al. Prevention of vascular and neural dysfunction in diabetic rats by C-peptide. Science. 1997;277(5325):563–566; doi: 10.1126/science.277.5325.563.
4.
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37(Suppl. 1):81–90; doi: 10.2337/dc14-S081.
5.
Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011;94(3):311–321; doi: 10.1016/j.diabres.2011.10.029.
6.
Makela AM. Theoretical backgrounds for light application in diabetes. Laser Florence; 2004.
7.
Verma SK, Maheshwari S, Singh RK, Chaudhari PK. Laser in dentistry: an innovative tool in modern dental practice. Natl J Maxillofac Surg. 2012;3(2):124–132; doi: 10.4103/0975-5950.111342.
8.
Svelto O, Hanna DC. Properties of laser beams. In: Svelto O, Hanna DC (eds.), Principles of lasers. Boston: Springer; 1982; 269–295.
9.
Lin F, Josephs SF, Alexandrescu DT, Ramos F, Bogin V, Gammill V, et al. Lasers, stem cells, and COPD. J Transl Med. 2010;8:16; doi: 10.1186/1479-5876-8-16.
10.
Hamblin MR. Ultraviolet irradiation of blood: “The cure that time forgot”? Adv Exp Med Biol. 2017;996:295–309; doi: 10.1007/978-3-319-56017-5_25.
11.
Gasparyan L. Laser irradiation of the blood. Laser Partner-Clinixperience. 2003;1–4.
12.
Farivar S, Malekshahabi T, Shiari R. Biological effects of low level laser therapy. J Lasers Med Sci. 2014;5(2):58–62; doi: 10.22037/JLMS.V5I2.5540.
13.
Litscher G, Litscher D. A laser watch for simultaneous laser blood irradiation and laser acupuncture at the wrist. Integr Med Int. 2016;3(1–2):75–81; doi: 10.1159/000448099.
14.
Litscher G, Bahr F, Litscher D. Yellow laser stimulation on the skull – first evidence of microcirculatory changes in the laboratory [in German]. Akupunktur & Aurikulomedizin. 2015;41(1):33–36; doi: 10.1007/s15009-015-5319-y.
15.
Brill G, Gasparyan L, Makela AM. Modification in relationships in the system endothelial cell-blood platelet by low level laser radiation. Laser Florence; 2003.
16.
Yosten GLC, Maric-Bilkan C, Luppi P, Wahren J. Physiological effects and therapeutic potential of proinsulin C-peptide. Am J Physiol Endocrinol Metab. 2014;307(11):955–968; doi: 10.1152/ajpendo.00130.2014.
17.
Makela AM. Clinical observations on effects of laser light on blood glucose levels in diabetics. Laser Florence Abs, Suppl. Laser in Medical Science. London: Springer; 2005.
18.
Longo L. The role of laser in diabetes management. In: Waynant R, Tata DB (eds.), Proceedings of Light-Activated Tissue Regeneration and Therapy Conference. Boston: Springer; 2008; 215–220.
19.
Kazemi Khoo N, Iravani A, Arjmand M, Vahabi F, Lajevardi M, Akrami SM, et al. A metabolomic study on the effect of intravascular laser blood irradiation on type 2 diabetic patients. Lasers Med Sci. 2013;28(6):1527–1532; doi: 10.1007/s10103-012-1247-4.
20.
Makela AM. Role of L-arginine in the biological effects of blue light. In: Zhu J (ed.), 2004 Shanghai International Conference on Laser Medicine and Surgery. Proceedings of the SPIE, vol. 5968. 2005; 32–44.
21.
Monti LD, Setola E, Lucotti PCG, Marrocco-Trischitta MM, Comola M, Galluccio E, et al. Effect of a long-term oral L-arginine supplementation on glucose metabolism: a randomized, double-blind, placebo-controlled trial. Diabetes Obes Metab. 2012;14(10):893–900; doi: 10.1111/j.1463-1326.2012.01615.x.
22.
Wang T, Dong W, Xiao Y, Lin Y, Xuan G. Effects of low-energy He-Ne laser irradiation of extracorporeally circulatory blood on ATPase activities of erythrocyte membrane in patients with IDDM. Laser J. 1992;6:011.
23.
Kazemikhoo N, Ansari F, Nilforoushzadeh. The hypoglycemic effect of intravenous laser therapy in diabetic mellitus type 2 patients; a systematic review and meta-analyses. iMedPub Journals. 2015;1(1):7; doi: 10.21767/2471-299X.1000007.
24.
Irani S, Mohseni Salehi Monfared SS, Akbari-Kamrani M, Ostad SN, Abdollahi M, Larijani B. Effect of low-level laser irradiation on in vitro function of pancreatic islets. Transplant Proc. 2009;41(10):4313–4315; doi: 10.1016/j.transproceed.2009.09.065.
25.
Ramdawon P. Bioresonance information laser therapy of diabetes mellitus: a first clinical experience of the hypoglycemic effect of low level laser therapy and its perspectives. Paper presented at the North American Laser Therapy Association Conference. Washington: Rockville; 1999.
| eISSN: | 2544-4395 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
